News

Geoffrey Johnson, MD, PhD, the Chair of Nuclear Medicine at Mayo Clinic, presented first in human imaging data from Perspective’s melanoma-targeted product VMT01

Geoffrey Johnson, MD, PhD, the Chair of Nuclear Medicine at Mayo Clinic, presented first in human imaging data from Perspective’s melanoma-targeted product VMT01 at the Annual Society of Nuclear Medicine and Molecular Imaging meeting in Chicago, IL. This exciting product has now entered a therapeutic trial. Watch to learn more!

CEO Lori Woods with Proactive on the pending merger with Viewpoint Molecular Targeting

CEO Lori Woods with Proactive financial media discussing the Isoray merger with Viewpoint Molecular Targeting, Inc. and the big opportunity it represents in 2023

Scroll to top